O v vijayan biography of michael jackson
•
O. V. Vijayan
Recognized by over 1,000,000 people
Age
74 years old at time of death
Family
| siblings |
|
Birth
Death
Work
Locations
Languages
Education
Accomplishments
Personal
•
Moments in Arts and Sports of Independent India
On August 15th, 2022, independent India will be 75 years old. That is old age for a human being but for a nation, it is about when maturity dawns. Politics is its driver but what gives it direction, pointing to the virtuous route, is the sphere of culture. Our moment of freedom was heralded by the shehnai of Bismillah Khan playing from the Red Fort. India’s march to itself had begun. It has been a journey of self-awareness and imagination. From the roiling that accompanied the birth, as told in the pages of Amrita Pritam’s Pinjar (1950), to the magical half-autobiography of a nation in Midnight’s Children (1981). It is the story of scale and craft, the line that goes from Mughal-e-Azam (1960) to Baahubali (2015). Of strength, from the near-miss of Milkha Singh to the Olympics gold of Neeraj Chopra. No country can be contained in 75 moments, but these remain milestones of the work in progress.
August 15, 1947: Bismillah Khan • Tumour necrosis factor α (TNFα) fryst vatten a pivotal cytokine in host defences with broad ranging effects on the innate and adaptive immune systems. Clinically, TNFα inhibitors have demonstrated remarkable efficacy in a wide range of autoimmune and inflammatorisk disorders but clearly at the cost of heightened susceptibility to a variety of infections in those treated with these agents. Most reports to date have described increased susceptibility to intracellular pathogens in patients with underlying chronic viral infections, but little in the way of adverse event reporting in these patients has occurred. While the reported experience to date is rather limited, TNFα inhibitors have displayed a reasonable safety profile in the setting of some chronic viral infections and in certain circumstances have demonstrated adjunctive activity in the treatment of these infections. Given the high prevalence of chronic viral infections in patients who are candidates for anti-TNF therapy and the
Abstract